What is Cryoablation Therapy?
Operating at the intersection of advanced medical technology and patient-centered care, Cryoablation Therapy provides comprehensive obstetrics and gynecology services. The practice, led by Dr. William N. Landry, III, MD, distinguishes itself through the utilization of minimally invasive surgical techniques, including the da Vinci robotic system. By focusing on high-demand areas such as hormone replacement therapy and specialized cryoablation procedures, the company maintains a robust market position within the St. Tammany Parish and Covington, Louisiana regions. The firm's commitment to combining clinical expertise with cutting-edge hardware ensures a high standard of care for menopause management and prenatal health.
How much funding has Cryoablation Therapy raised?
Cryoablation Therapy has raised a total of $125K across 1 funding round:
Debt
$125K
Debt (2021): $125K with participation from PPP
Key Investors in Cryoablation Therapy
PPP
Public-Private Partnership
What's next for Cryoablation Therapy?
The infusion of capital is expected to catalyze the next phase of growth for the practice, likely focusing on the expansion of its surgical infrastructure and the enhancement of its technological capabilities. As the company transitions through this late-stage funding cycle, the strategic priority will shift toward optimizing patient throughput and broadening the scope of its minimally invasive offerings. By leveraging this financial backing, the organization aims to solidify its reputation as a leader in regional women's health, potentially exploring further integration of robotic-assisted surgical platforms to improve patient outcomes and operational efficiency.
See full Cryoablation Therapy company page
